Cizzle Biotechnology Holdings Plc (CIZ.L)
GBp 1.5
(-3.23%)
GBp 1.5
(-3.23%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | 74 Thousand |
| Cost of Revenue | - | - | - | - | - | 29 Thousand |
| Gross Profit | - | - | - | - | - | 45 Thousand |
| Operating Expenses | 1190.00 | 963 Thousand | 851 Thousand | 229 Thousand | 21.71 Thousand | 1.27 Million |
| Selling, General and Administrative Expenses | 976.00 | 381 Thousand | 266 Thousand | 229 Thousand | 21.71 Thousand | 1.33 Million |
| Research and Development Expenses | 214.00 | 280 Thousand | 161 Thousand | - | - | - |
| Other Expenses | - | 302 Thousand | 424 Thousand | - | - | -54 Thousand |
| Cost and Expenses | 1190.00 | 963 Thousand | 851 Thousand | 229 Thousand | 21.71 Thousand | 1.3 Million |
| Operating Income | -1190.00 | -963 Thousand | 2.25 Million | -306 Thousand | -21.71 Thousand | -1.73 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -46 Thousand | -51 Thousand | -37 Thousand | -77 Thousand | -2.00 | -118 Thousand |
| Earnings before Tax | -1763.00 | -963 Thousand | -3.95 Million | -306 Thousand | -21.7 Thousand | -1.73 Million |
| Net Income | -1717.00 | -910 Thousand | -3.92 Million | -310 Thousand | -830 Thousand | - |
| Earnings Per Share Basic | - | -0.00 | -0.02 | -0.01 | -0.02 | - |
| Earnings Per Share Diluted | - | -0.00 | -0.02 | -0.00 | -0.00 | - |
| Weighted Average Shares Outstanding | 355.92 Million | 291.32 Million | 160.52 Million | 42.88 Million | 42.88 Million | 313 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 355.86 Million | 291.32 Million | 160.52 Million | 253.45 Million | 253.45 Million | 313.93 Thousand |
| Gross Margin | - | - | - | - | - | 0.61 |
| EBIT Margin | - | - | - | - | - | -8.22 |
| Profit Margin | - | - | - | - | - | -27.80 |
| EBITDA | - | -963 Thousand | - | -306 Thousand | -20.26 | -1.19 Million |
| Earnings Before Tax Margin | - | - | - | - | - | -23.42 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 149.50 | 149.50 | 653.00 | 976 Thousand | 653.00 | 457 Thousand |
| Selling, General and Administrative Expenses | 149.50 | 149.50 | 317.00 | - | 317.00 | 457 Thousand |
| Research and Development Expenses | - | - | 107.00 | - | 107.00 | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 149.50 | 149.50 | 653.00 | 976 Thousand | 653.00 | 457 Thousand |
| Operating Income | -149.50 | -149.50 | -317.00 | -976 Thousand | -317.00 | -457 Thousand |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 5.00 | 5.00 | 10.00 | -46 Thousand | 10.00 | -26 Thousand |
| Earnings before Tax | -710.50 | -710.50 | -653.00 | -1.76 Million | -653.00 | -457 Thousand |
| Net Income | -705.50 | -705.50 | -643.00 | -1.71 Million | -643.00 | -430 Thousand |
| Earnings Per Share Basic | - | - | - | - | - | -0.00 |
| Earnings Per Share Diluted | - | - | - | - | - | -0.00 |
| Weighted Average Shares Outstanding | 378.48 Million | 378.48 Million | 364.09 Million | 355.86 Million | 364.09 Million | 347.77 Million |
| Weighted Average Shares Outstanding (Diluted) | 378.32 Million | 378.32 Million | 363.95 Million | 355.86 Million | 363.95 Million | 347.77 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -1.42 Million | 10.00 | -316.00 | - | -316.00 | -457 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
DPBSF
SBS
0QKR
013A
NDGPY
603038